Your browser doesn't support javascript.
loading
Systemic lupus erythematosus: one year in review 2023.
Zucchi, Dina; Silvagni, Ettore; Elefante, Elena; Signorini, Viola; Cardelli, Chiara; Trentin, Francesca; Schilirò, Davide; Cascarano, Giancarlo; Valevich, Anastasiya; Bortoluzzi, Alessandra; Tani, Chiara.
Afiliação
  • Zucchi D; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy. dinazucchi@hotmail.it.
  • Silvagni E; Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.
  • Elefante E; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Signorini V; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Cardelli C; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.
  • Trentin F; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Schilirò D; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Cascarano G; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Valevich A; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Bortoluzzi A; Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.
  • Tani C; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Clin Exp Rheumatol ; 41(5): 997-1008, 2023 May.
Article em En | MEDLINE | ID: mdl-37133502
ABSTRACT
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations and a relapsing-remitting course. New data regarding pathogenic pathways, biomarkers and clinical manifestations of SLE are emerging, and new drugs and therapeutic protocols have been proposed to improve the control of disease activity. Furthermore, new insights into comorbidities and reproductive health in SLE patients are constantly emerging.This annual review aims to summarise the most relevant data on SLE that was published in 2022.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Lúpus Eritematoso Sistêmico Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Lúpus Eritematoso Sistêmico Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália